Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenectomy for myelofibrosis

H Järvinen, E Kivilaakso, E Ikkala

    Annals of Clinical Research
    |April 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Establishing the European diagnostic reference levels for interventional cardiology.

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2018
    Same author

    Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland.

    BMJ open gastroenterology·2015
    Same author

    Characterisation of grids of point detectors in maximum skin dose measurement in fluoroscopically-guided interventional procedures.

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2015
    Same author

    Characterization of XR-RV3 GafChromic(®) films in standard laboratory and in clinical conditions and means to evaluate uncertainties and reduce errors.

    Medical physics·2015
    Same author

    Collective effective dose in Europe from X-ray and nuclear medicine procedures.

    Radiation protection dosimetry·2015
    Same author

    Indication-based national diagnostic reference levels for paediatric CT: a new approach with proposed values.

    Radiation protection dosimetry·2015

    Splenectomy for myelofibrosis (MF) offers significant symptomatic relief and can improve blood counts, but carries risks. Early surgery, especially when cytopenia is present, is recommended to minimize complications.

    Area of Science:

    • Hematology
    • Surgical Oncology

    Background:

    • Myelofibrosis (MF) is a bone marrow disorder often associated with debilitating symptoms like massive splenomegaly and cytopenias.
    • Splenectomy is a potential treatment option for symptomatic MF, but its risks and benefits require careful evaluation.

    Purpose of the Study:

    • To evaluate the outcomes of splenectomy in patients with myelofibrosis (MF).
    • To assess the impact of splenectomy on operative mortality, postoperative complications, and patient hematological status.

    Main Methods:

    • A retrospective analysis of 30 consecutive splenectomies performed for myelofibrosis (MF).
    • Data collected included operative mortality, postoperative complications, intraoperative blood loss, and long-term patient benefit.

    Main Results:

    Related Experiment Videos

    • Operative mortality was 6.7%, with 37% of patients experiencing postoperative complications.
    • Patients operated on within one year of MF diagnosis had significantly lower morbidity (13%) compared to those operated on later (64%).
    • 79% of patients with anemia and/or thrombocytopenia showed definite benefit, with improved hematological status and reduced transfusion needs.

    Conclusions:

    • Splenectomy in MF provides considerable symptomatic relief and can improve hematological parameters, though it may not prolong survival.
    • Early surgical intervention, particularly upon the onset of cytopenia, is advised to mitigate the increased risks associated with delayed splenectomy.